Fellow blogger Toby Bloomberg over at Diva Marketing writes a review of two pharma companies who are beginning to explore the blogosphere. GSK’s effort is focused on just-released OTC product ALLI; J&J’s blog is more general. Check out Toby’s summary and the links provided.
Steve – if 2 big brand pharma companies can take a dive into social media should give courage to other brands that don’t deal in ‘brain surgery’ products or services .. wouldn’t you think?
It all boils down to the regulated environment…pharma, as you know, is highly regulated, and all communications undergo lots of scrutiny. It’s one of my biggest frustrations with the pharma/biotech sector – the highly-controlled, centralized communication model is the antithesis of where the web is going.